Premjit Amornchai
Contact information
Podcast interview
MORU Biosafety Level 3 and melioidosis in Thailand
Melioidosis is endemic at least 45 countries, but greatly under-reported, with a microbiological culture required to confirm diagnosis. Premjit works with MORU researchers who have produced a rapid diagnostic test that aims to improve both diagnosis and public awareness of melioidosis.
Colleges
Premjit Amornchai
Laboratory manager
Microbiology
I am a BSL3 lab manager at MORU and my responsibility is to perform full scale management for BSL3 lab facilities, including finding work space and equipment, providing induction safety training, solving problems and finding out the solution to make our staff work safely and happy in the lab. My research interest is melioidosis and leptospirosis.
Recent publications
-
Prevalence of extended-spectrum β-lactamase-producing Enterobacterales in edible ice in Thailand.
Journal article
Amornchai P. et al, (2024), Int Health
-
Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021.
Journal article
Tantirat P. et al, (2024), Emerg Infect Dis, 30, 791 - 794
-
Effectiveness of Umonium38 against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA).
Journal article
Ruanchaiman S. et al, (2024), BMC Infect Dis, 24
-
BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection.
Journal article
Angchagun K. et al, (2023), Wellcome Open Res, 8
-
Sensitivity and specificity of DPP® Fever Panel II Asia in the diagnosis of malaria, dengue and melioidosis.
Journal article
Amornchai P. et al, (2022), J Med Microbiol, 71